ACLS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ohwovoriole, A.
Right arrow Articles by Johnson, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ohwovoriole, A.
Right arrow Articles by Johnson, T.
Annals of Clinical and Laboratory Science, Vol 14, Issue 4, 265-269
Copyright © 1984 by Association of Clinical Scientists


Articles

Influence of methodology on glycosylated hemoglobin values in Nigerian subjects with sickle cell hemoglobinopathy

AE Ohwovoriole, JA Kuti, and TO Johnson

The determination of glycosylated hemoglobin (GHb) has been found useful in the medium term assessment of diabetic control. Levels of GHb have been shown to be influenced by hematological abnormalities and methodology amongst other factors. Hemoglobinopathies are common in Nigerians and other people of African descent. No work, to our knowledge, has been done in Nigeria to study the effect of hemoglobinopathies on the levels of GHb in Nigerians or Africans. In this study, GHb levels in non-diabetic Nigerians (with hemoglobin genotypes AA, AS, and SS) were determined by short column chromatography and thiobarbituric acid colorimetry. Levels of GHb obtained by the microchromatographic method were significantly different from one another in the three subject groups. The group mean GHb level was highest in subjects with sickle cell anaemia and lowest in subjects with sickle cell trait. However, using the colorimetric method, the mean GHb level of the normal subjects with hemoglobin genotype AA was not significantly different from that of subjects with hemoglobin genotype AS or SS. Results of GHb determinations by microchromatography (for which several commercial kits are available) in subjects with sickle cell anemia or trait must be interpreted with caution. The colorimetric method, though more tedious, gives more reliable results and should be the method of choice in subjects with concurrent diabetes and sickle cell anemia or trait.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1984 by the Association of Clinical Scientists.